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Abstract: It is well established that muscle contractions during exercise lead to elevated 
levels of reactive oxygen species (ROS) in skeletal muscle. These highly reactive molecules 
have many deleterious effects, such as a reduction of force generation and increased 
muscle atrophy. Since the discovery of exercise-induced oxidative stress several decades 
ago, evidence has accumulated that ROS produced during exercise also have positive 
effects by influencing cellular processes that lead to increased expression of antioxidants. 
These molecules are particularly elevated in regularly exercising muscle to prevent the 
negative effects of ROS by neutralizing the free radicals. In addition, ROS also seem to  
be involved in the exercise-induced adaptation of the muscle phenotype. This review provides 
an overview of the evidences to date on the effects of ROS in exercising muscle. These 
aspects include the sources of ROS, their positive and negative cellular effects, the role of 
antioxidants, and the present evidence on ROS-dependent adaptations of muscle cells  
in response to physical exercise. 
Keywords: skeletal muscle; ROS; exercise; mitochondria; force generation;  
antioxidants; PGC-1 
 
1. Introduction 
Skeletal muscle is a highly specialized tissue with excellent plasticity in response to external stimuli 
such as exercise and training. The repetitive muscle contractions conducted during endurance training 
lead to a variety of phenotypic and physiological responses. These responses include activation of 
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mitochondrial biogenesis, fiber type transformation and angiogenesis. Together, they increase the 
muscle’s capacity of aerobic metabolism and its resistance to fatigue. High muscle activity also involves 
a strong increase in reactive oxygen species (ROS) production. These unstable molecules and ions 
contain oxygen and are extremely reactive due to an unpaired electron. Among these oxygen 
intermediates are the free radicals superoxide, peroxide and the hydroxyl radicals and other highly 
reactive oxidants, such as singlet oxygen and hypochlorous acid. They promote oxidation reactions 
with other molecules, such as proteins, lipids and DNA and can thus be highly detrimental. However, 
recent research has demonstrated that ROS also have a beneficial role in promoting the adaptive 
responses of muscle to training. 
More than three decades ago it was established that muscle activity leads to an increase in ROS 
production and concentration of free radicals [1,2]. Since then numerous investigations in rodents  
and humans have confirmed these early observations. Thus, it is generally accepted that single bouts of 
aerobic or anaerobic exercise, as well as chronic exercise promote the generation of ROS (summarized 
in the reviews [3,4]; and more recently e.g., [5–7]). 
The great interest in this topic also stems from data that show that ROS levels are increased in 
subjects with aging-related sarcopenia, cardiac reperfusion injuries or muscular diseases, i.e., muscle 
dystrophies. Thus, it was assumed that exercise-induced ROS are potentially detrimental to muscle 
function and lead to muscle fatigue and muscle atrophy. Hence, many investigations focused on ways 
to prevent ROS production and accumulation and subsequent oxidative damage during and following 
physical exercise. 
2. Sources of ROS in Muscle 
It has consistently been shown that muscle activity leads to a strong increase in ROS production [8]. 
However, there is a large debate about the sources and the extent of ROS that these sources produce. 
Several potential producers of ROS have been identified in muscle cells which are likely to be activated 
by different stimuli. Among these are mitochondria, nicotinamide adenine dinucleotide phosphate 
(NADPH) oxidases (NOXs), phospholipase A2 (PLA2), xanthine oxidase (XO) and lipoxygenases 
(Figure 1). Some of these are discussed in more detail below. In addition to these intracellular sources, 
ROS has been shown to be produced from non-muscle sources. Strenuous exercise can elicit muscle 
injuries, which then lead to the activation of the neutrophils and macrophages via interferon- (IFN-), 
interleukin-1 (IL-1) and tumor necrosis factor (TNF) (for more detailed information see reviews [9,10]). 
These immune cells excessively produce ROS (oxidative burst), which is a central component of 
neutrophil defense mechanism. In addition, the exercise-induced increase of catecholamines (adrenaline, 
noradrenaline, dopamine) also play a role in the generation of ROS [11], as well as ROS derived  
from endothelium [12] (Figure 1). 
2.1. Mitochondria 
For a long period of time, mitochondria were regarded as the main producer of cellular ROS with an 
estimated superoxide production rate of approximately 1%–4% of total mitochondrial O2 consumption  
(see reviews [8,13,14]). More recent data demonstrate that the production of ROS in mitochondria  
is by an order of magnitude smaller than originally expected and is approximately 0.15% [15]. 
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Mitochondria are thought to produce ROS by a leak of single electrons in the respiratory chain in the 
mitochondrial inner membrane of the contracting muscle cells. Ten different sites of superoxide/H2O2 
generation have been found as yet in mammalian mitochondria [16,17]. Superoxide production mainly 
occurs from complexes I (NADH dehydrogenase) and III (coenzyme Q and cytochrome C oxidoreductase) 
of the electron transport chain [18,19]. New findings also identify complex II (succinate dehydrogenase) 
as a major source of superoxide production [16]. Using isolated mitochondria, the contribution of  
each site to total H2O2 production has recently been quantified and shown to strongly depend on  
the substrate being oxidized [20]. At rest, H2O2 was predominantly produced from the quinol site in 
complex I (site IQ) and flavin site in complex II (site IIF), followed by sites IF and IIIQo. Under conditions 
that mimic mild and intense aerobic exercise, total production is much less and the low capacity site IF 
dominates [20]. 
 
Figure 1. Sources of reactive oxygen species (ROS) and endogenous antioxidants in 
skeletal muscle fibers. Following exercise, ROS are produced endogenously by mitochondria, 
NOXs, PLA2 and XO. In addition, exercise increases ROS production also in activated 
neutrophils and macrophages, endothelia of blood vessels and by catecholamines. Regular 
exercise leads to an increase of endogenous antioxidants, which are able to neutralize  
free radicals. A, adrenaline; CAT, catalase; Cu, Zn-SOD, copper-zinc superoxide dismutase; 
DA, dopamine; GPX, glutathione peroxidase; GSH, glutathione; IFN, interferon ;  
IL-1, interleukin-1; Mn-SOD, manganese superoxide dismutase; NA, noradrenaline;  
NOX, nicotinamide adenine dinucleotide phosphate oxidase; PLA2, phospholipase A2; 
SR, sarcoplasmic reticulum; TNF, tumor necrosis factor; TxnRd2, thioredoxin reductase 2; 
XO, xanthine oxidase. 
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2.2. NADPH Oxidases 
NADPH oxidases (NOXs) are flavoprotein enzymes that are activated by calcium, free fatty acids, 
protein-protein interactions and posttranslational modifications and use NADPH as electron donors [21,22]. 
They are transmembrane proteins in the transverse tubules and the sarcoplasmic reticulum and transport 
electrons across biological membranes to reduce oxygen to superoxide or H2O2 [21,22]. It was shown 
that NOX family members contribute to cytosolic superoxide production in skeletal muscle both at rest 
and during contractile activity to a larger extent than mitochondria [23–25]. ROS generated by NOXs 
activates ryanodine receptors (RyR), which leads to an intracellular Ca2+ release [26–28]. More recently,  
it was found that insulin induces ROS generation through NOX activation and that this ROS increase 
is required for the intracellular Ca2+ rise mediated by inositol triphosphate (IP3) receptors [29]. 
2.3. Xanthine Oxidase 
Xanthine oxidase (XO) is a cytosolic molybdoflavoenzyme that is recognized as a key enzyme in 
purine catabolism in which it catalyzes the hydroxylation of hypoxanthine to xanthine and of xanthine 
to uric acid [30]. In muscle, XO is present in the cytosol but also in the associated endothelial cells [8]. 
Upon contraction, XO activity is significantly increased and leads to increased lipid peroxidation, protein 
oxidation, muscle damage and edema [31]. During intense exercise in which large amounts of ATP  
are consumed, hypoxanthine and xanthine levels are rising and serve as substrates for XO to generate 
ROS [32]. Interestingly, ROS generated by XO appears to be involved in the regulation of exercise-induced 
mitochondrial biogenesis via peroxisome proliferator-activated receptor- coactivator-1 (PGC-1) [33]. 
2.4. Myostatin 
Recently, it was demonstrated that myostatin, a blocker of muscle differentiation, is capable of 
signaling ROS production via canonical Smad3, nuclear factor (NF)-B and TNF- in muscle cells [34]. 
In the absence of Smad3, myostatin induces ROS production through the activation of p38 and ERK 
mitogen-activated protein kinase (MAPK) pathways mediated via TNF- , IL-6, NOX and XO [35]. 
2.5. Phospholipase A2 
Enzymes of the phospholipase A2 (PLA2) family also contribute to intra- and extracellular ROS 
increase during muscle contraction. They cleave arachidonic acid from phospholipids in the plasma 
membrane, sarcoplasmic reticulum or mitochondrial membranes. Arachidonic acid is an important 
lipid-signaling molecule and is a substrate for lipoxygenases for the production of ROS [36]. In addition, 
the cytosolic PLA2 enzyme has been demonstrated to increase ROS by stimulating NOXs [37]. Human 
muscle is known to contain approximately 15 different PLA2 isoforms that are either Ca2+-sensitive or 
Ca2+-insensitive [38]. The Ca2+-independent and dependent enzymes are supposed to produce ROS 
under resting and activity conditions, respectively [39]. 
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3. Effects of ROS on Force Generation and Muscle Atrophy 
In unfatigued muscle, intracellular ROS appear to be essential for normal force generation.  
Low-level ROS supplementation even increases force production [40]. A stronger increase of ROS  
due to intense exercise leads to a variety of adaptations of the muscle cells. Dependent upon the ROS 
concentration, duration of ROS exposure and training status of the individual, ROS can have beneficial 
and detrimental effects (Figure 2). Thus, a single bout of exhaustive exercise has been shown to cause 
oxidative damage in untrained persons while in trained subjects, no such effects are observed due to an 
increased resistance of such persons to oxidative stress [41]. Strong increases in ROS after strenuous 
exercise, aging and/or disease (e.g., chronic heart failure, COPD, cancer) can cause contractile dysfunction 
and muscle atrophy, which both promote muscle weakness and fatigue [3,42]. 
 
Figure 2. Deleterious and beneficial effects of exercise-induced ROS increase. Exercise 
produces ROS and whether they are beneficial or detrimental to health is dependent upon 
the ROS concentration, duration of ROS exposure and training status of the individual.  
A single bout of exhaustive exercise leads to strong increases of ROS, which cannot be 
buffered by endogenous antioxidants, particularly in untrained individuals. This results in 
severe oxidative damage, including muscle weakness and fatigue, DNA mutations, lipid 
peroxidation, mitochondrial dysfunction and apoptosis/necrosis. Trained persons have a higher 
level of adaptation and less health risks. ROS produced during regular exercise continuously 
increase the level of adaptation by improving antioxidant capacity, mitochondrial biogenesis, 
insulin sensitivity, cytoprotection and aerobic capacity of skeletal muscle. 
3.1. Contractile Dysfunction 
Contractile dysfunction may result from oxidative modifications of a variety of proteins in diverse 
intracellular components [43,44]. However, our understanding of the processes involved is still limited 
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and many data are equivocal. In the sarcoplasmic reticulum, the ryanodine receptor (RyR), which is 
the Ca2+ release channel, was shown to be oxidized by ROS and it was hypothesized to contribute to 
muscle fatigue [26–28]. However, other work demonstrated that this oxidation resulted only in increased 
Ca2+-induced Ca2+ release, whereas the Ca2+ release triggered by action potentials was not affected [45,46]. 
From this it was inferred that ROS-mediated effects on Ca2+ release in the sarcoplasmic reticulum  
are unlikely to contribute to muscle fatigue. This goes in line with recent findings that demonstrate that 
the mitochondrial antioxidant SS-31 restored the decrease in sarcoplasmic reticulum Ca2+ release while 
force recovery was not improved [47]. 
Similar uncertainty surrounds the effect of ROS on the force generating myofilaments. Initial data 
have shown that brief exposure to low concentrations of H2O2 increased force by 27%, while a longer 
exposure results in force decline [48]. By contrast, a short exposure of skinned fibers to 10 mM H2O2 
had no effect on maximum force [45], while longer exposure to 50 mM H2O2 inhibited contractility [49]. 
Although the exact mechanisms are unknown, it is generally assumed that changes in force generation 
are the result of changes in the myofibrillar Ca2+ sensitivity [8,44,47]. In this regard, it was most 
recently suggested that troponin I, which is involved in sensing the intracellular Ca2+ levels, is a target 
of ROS. Oxidized cysteine residues of troponin I can react with the antioxidant glutathione, which 
helps protect the molecule from oxidative stress and make the contractile apparatus much more sensitive 
to Ca2+ [50]. However, it must be mentioned that ROS may also lead to changes in the contractile 
proteins. In this regard, it was demonstrated that H2O2 is able to modify the S1 fragment in the myosin 
head, which then leads to a restriction of the myosin-actin dynamics in the presence of ATP [49]. 
3.2. Muscle Atrophy 
Besides their effects on the contractile kinetics, ROS are also able to modulate various signaling 
pathways, such as calcium, protein tyrosine kinases and phosphatases, serine/threonine kinases, and 
phospholipases [51]. This then leads to changes in gene expression, cell function, metabolism or cell damage. 
Chronic oxidative stress is associated with an increase in protein loss and muscle atrophy. High ROS 
levels cause a sustained activation of NF-B and of FoxO which then activate two muscle-specific  
E3 ubiquitin ligases, atrogin-1 or muscle atrophy F-box (MAFbx) and muscle RING (Really Interesting 
New Gene)-finger protein 1 (MuRF-1) [52]. MAFbx and MuRF-1 then degrade various proteins,  
such as titin, nebulin, troponin, myosin-binding protein C, myosin light chains 1 and 2 and myosin 
heavy chain [53,54]. Recently, it was demonstrated that excessive oxidative stress also enhances  
the transcription factor C/EBP homology protein (CHOP). This transcription factor also enhances 
expression of MuRF1, which again results in increased protein degradation [35]. 
4. Antioxidants in Muscle 
4.1. Enzymatic and Nonenzymatic Antioxidants 
Muscle activity increases ROS but simultaneously also the body’s antioxidant defense system. 
These molecules are able to neutralize free radicals by accepting the unpaired electron and thereby 
inhibit the oxidation of other molecules. Depending on the oxygen consumption rate, cells constitutively 
express different levels of antioxidant enzymes, including mitochondrial antioxidant manganese 
Biomolecules 2015, 5 362 
 
 
superoxide dismutase (Mn-SOD, SOD2), cytosolic copper-zinc superoxide dismutase (Cu, Zn-SOD, SOD1), 
glutathione peroxidase (GPX) and catalase (CAT), and the nonenzymatic antioxidant glutathione 
(GSH) [55] (Figure 1). 
GSH is the most abundant nonprotein thiol in cells with intracellular concentrations of 1–15 mM [56]. 
It plays a major role in the detoxification of electrophilic xenobiotics, such as chemical carcinogens, 
environmental pollutants, and the inactivation of endogenous ,-unsaturated aldehydes, quinones, 
epoxides, and hydroperoxides, which are formed as secondary metabolites during oxidative stress via 
members of the glutathione transferase family [57]. It also protects from oxidative stress by reducing 
hydrogen peroxide and organic peroxides levels via a reaction catalyzed by GSH peroxidase thus 
keeping the intracellular environment in the reduced state [55,58]. In addition, GSH is a substrate for 
dehydroascorbate reductase enabling the recycling of ascorbic acid, and it is a scavenger of hydroxyl 
radicals and singlet oxygen [59]. 
The aforementioned enzymatic reactions lead to the oxidation of GSH to glutathione disulfide 
(GSSG). This molecule can inactivate a number of enzymes by reacting with protein thiols leading to 
the formation of mixed disulfides (e.g., [60]). To avoid damage to intracellular constituents, GSSG is 
efficiently reduced to GSH by glutathione reductase (GR) utilizing NADPH. This action of GR is  
also very important during and after exercise in which a substantial amount of GSH is oxidized due to 
the elevated ROS levels to keep the GSH/GSSG ratio constant thereby maintaining homeostasis. 
Furthermore, exercising skeletal muscle appears to increase GSH import from plasma [61,62], and 
liver can synthesize GSH de novo and supply it [58]. But also increased muscle glutathione synthetase 
activities have been observed after treadmill training [63]. These exercise responses are tissue- and  
fiber-specific [64]. 
The antioxidant enzymes SOD, CAT and GPX are the primary defense against ROS generated 
during exercise and increase in response to exercise [65,66]. Recent work identified thioredoxin 
reductase-2 (TxnRd2) as another key player to decrease the exercise-induced content of mitochondrial 
H2O2 in skeletal muscle [67]. The same authors have shown that TxnRd2 is also able to control 
mitochondrial H2O2 levels after a high-fat, high-sucrose diet in the heart but not in skeletal muscle. 
Antioxidant enzyme levels vary considerably with respect to muscle fiber types, i.e., type I muscle 
fibers possess higher activity of all antioxidant enzymes than the type IIA and type IIB fibers [68]. 
4.2. Adaptive Responses to Exercise 
In general, it was found that there is an exercise-induced increase in antioxidant protein levels and 
antioxidant activity. Thus, endurance training in rats leads to an increase in Mn-SOD, GPX and CAT, 
while the data on Cu, Zn-SOD are somewhat less clear [69–73]. Note that from the above studies, it is 
likely that upregulation of these antioxidants is muscle- and/or fiber type-specific. Many studies have 
shown that even an acute bout of exercise increases SOD activity in skeletal muscle ([74–77]; for 
review see [55]), and it has further been shown that Cu, Zn-SOD and Mn-SOD contents are increased. 
While the Cu, Zn-SOD enzyme activity gradually returns to resting levels within three days, Mn-SOD 
activity and protein content continues to increase in the post-exercise period [78]. GPX activity after 
acute exercise on the other hand appears to depend on the muscle type, i.e., GPX activity was 
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increased a day after an acute bout of treadmill running to exhaustion in rat soleus but not tibialis 
muscle [78], and CAT activity appears not to be altered by acute exercise [65].  
ROS generated by acute exercise can lead to increased lipid peroxidation as measured by the 
formation of malondialdehyde [79]. Interestingly, this effect was only found in liver and fast skeletal 
muscle in the sedentary group, whereas the endurance-trained group did not show increases in lipid 
peroxidation after exercise. Lipid peroxidation generates a vast number of oxidative lipid breakdown 
products for which more or less specific tests are available (for review see [59]. Some investigators 
determined plasma isoprostane levels in athletes performing either a 50 km ultramarathon [80] or 
exercise for 2.5 h on a treadmill [81]. Peak levels of isoprostanes were found directly post-exercise, 
followed by a return to baseline within one day or one hour, respectively. Other investigators found 
increased levels of pentane in the breath after exercise [1], increased levels of lipid hydroperoxides [82], 
conjugated dienes [83] and oxidative DNA damage as measured by 8-hydroxydeoxyguanosine [84] or 
single cell gel electrophoresis [85]. The latter investigation gave results similar to those of Alessio and 
Goldfarb [79], namely a significant reduction of oxidative DNA damage in the trained compared to the 
untrained group indicating that exercise training causes an adaptive response to elevated oxidative stress 
by increased antioxidant enzyme activity. Powers et al. [86] studied the influence of training and observed 
significantly increased SOD activity in the soleus following exercise up to 60 min/d. Conversely, 
training induced significant increases in GPX activity in slow gastrocnemius only, and the magnitude 
of the GPX increase was directly related to exercise duration but relatively independent of intensity. 
However, CAT activity was not increased in any muscle with training. In addition, Radák et al. [87] 
observed decreased DNA damage and increased DNA repair levels as well as resistance against 
oxidative stress of proteins in aged rat skeletal muscle upon training. The obviously paradoxical situation 
that increased exercise-induced oxidative stress causes beneficial effects is interpreted in terms of 
hormesis—beneficial effects of potentially harmful agents—which apart from providing an adaptation 
to the damaging agent provide also systemic beneficial effects, including improved physiological 
function, decreased incidence of disease and a higher quality of life [88]. However, the beneficial 
effects appear to depend upon the duration of the exercise. While a single bout of exercise is suggested 
to lead to a limited adaptive response, regular exercise appears to gradually increase the level of 
adaptation by the repeated activation of antioxidant genes and proteins [32]. These authors hypothesize 
that it is the increased ROS level that is the important stimulus for the muscle cells to adapt to chronic 
exercise. The improved capabilities to decrease ROS may then provide a better protection from ROS 
during subsequent trainings but also attenuate the aging process and promote health with increased 
functional capacities [32]. Therefore, exercise is very similar to the adaptive ischemic preconditioning 
response [89]. Restoration of perfusion to ischemic organs results in increased ROS levels that can 
lead to tissue damage, myocardial infarction and stroke. However, such deleterious effects can be 
avoided by short intermittent bouts of reperfusion in which the transiently elevated ROS levels are 
important mediators of a cardioprotective response [89,90]. 
Important mediators of the adaptive responses are the adenosine monophosphate-activated protein 
kinase (AMPK), the transcription factors NF-B, together with p38 MAPK, and members of the FoxO 
transcription factor family [91–93]. At low ROS levels, they promote adaptation by increasing gene 
expression of antioxidant enzymes, such as Mn-SOD and Cu, Zn-SOD, CAT and GPX1 [94]. High 
antioxidant capacities then diminish the deleterious effects of subsequent increases in ROS [95].  
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In addition, products of radical reactions are also suggested to be the mediator of this adaptation. Of 
special interest in this context are lipid peroxidation products, in particular 4-hydroxynonenal (HNE), 
which has been shown to both induce DNA damage [96] but also to be involved in the regulation of 
cell proliferation and growth as well as necrotic or apoptotic cell death by its marked ability to modulate 
several major pathways of cell signaling and, consequently, gene expression (for review see [97]). 
With respect to antioxidant gene expression it has been shown to be one of the most effective activators 
of nuclear factor erythroid-derived 2-like 2 (Nrf2) [98] which on stimulation dissociates from its 
cytoplasmic inhibitor Keap1, translocates to the nucleus and transactivates antioxidant-responsive 
elements (ARE)-dependent genes [99]. In addition, HNE has been demonstrated to cause mitochondrial 
uncoupling and thus protection from ROS specifically via the induction of the uncoupling proteins 
UCP1, UCP2 and UCP3 and the adenine nucleotide translocase [100]. 
4.3. Exogenous Antioxidants and Exercise 
Apart from the endogenous antioxidants, which are obviously regulated by exercise, exogenous 
antioxidants such as vitamin C, E, and carotenoids are taken up with the food or are used as dietary 
supplements. The question therefore arises whether such supplements can be considered beneficial 
during exercise. To address this question, Ristow et al. [73] investigated the effects of a diet supplemented 
with vitamin C and E on exercise-induced insulin sensitivity as measured by glucose infusion rates 
during a hyperinsulinemic, euglycemic clamp in previously untrained and pre-trained healthy young 
men. Interestingly, exercise was found to increase parameters of insulin sensitivity (including 
adiponectin) only in the absence of antioxidants in both previously untrained and pretrained individuals. 
This was paralleled by increased expression of ROS-sensitive transcriptional regulators of insulin 
sensitivity and ROS defense capacity, peroxisome proliferator-activated receptor  (PPAR) and 
PPAR coactivators PGC-1 and PGC-1 only in the absence of antioxidants. Molecular mediators of 
endogenous ROS defense (Mn-SOD, Cu, Zn-SOD and GPX) were also induced by exercise, and this 
effect was again blocked by antioxidant supplementation. The authors concluded that exercise-induced 
oxidative stress ameliorates insulin resistance and causes an adaptive response promoting endogenous 
antioxidant defense capacity and that supplementation with antioxidants may preclude these health-promoting 
effects of exercise in humans. It was demonstrated that exercise causes an activation of mitogen-activated 
protein kinases (MAPKs: p38, ERK 1 and ERK 2), which in turn activates nuclear factor B (NF-B) 
in rat gastrocnemius muscle and consequently the expression of important enzymes associated with 
defense against ROS (SOD) and adaptation to exercise—endothelial nitric oxide synthase (eNOS) and 
inducible nitric oxide synthase (iNOS) [101–103]. The expression of these enzymes can be inhibited 
by allopurinol, an inhibitor of XO indicating also that the prevention of ROS formation causes an 
inhibition of an adaptive response. The authors therefore conclude that in all likelihood, antioxidant 
supplements should not be recommended before training as they interfere with muscle cell adaptation. 
Thus, physical exercise is considered a double-edged sword: when practiced strenuously it causes 
oxidative stress and cell damage; in this case application of antioxidants may be helpful. But when 
practiced in moderation, it increases the expression of antioxidant enzymes and thus should be 
considered an antioxidant [101,103]. Supportive evidence for this assumption comes from studies on 
physical overtraining. Margonis et al. [104] examined the responses of oxidative stress biomarkers to  
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a resistance training protocol of progressively increased and decreased volume/intensity in male test 
persons and observed significantly increased levels of urinary isoprostanes (7-fold), serum levels of 
thiobarbituric acid reactive substances (TBARS), protein carbonyls, CAT, GPX, and GSSG and 
significantly decreased levels of GSH, the GSH/GSSG ratio, and total antioxidant capacity in blood 
serum of over-trained individuals. Similarly, Palazzetti et al. [105] investigated the effects of overloaded 
training (OT) with athletes exercising for a duathlon before and after a four week OT and found that  
at rest conditions, OT induced an increased plasma GPX activity and a decreased plasma total 
antioxidant status, while OT resulted in higher exercise-induced variations of blood GSH/GSSG ratios, 
TBARS levels and decreased total antioxidant status in exercise conditions indicating that OT could 
compromise the antioxidant defense mechanisms. By comparing the oxidative stress response in 
control athletes and athletes with overtraining syndrome Tanskanen et al. [106] were further able to 
show that exercise to exhaustion led to an increase in oxygen radical absorbance (antioxidant) capacity 
and malondialdehyde in the controls but not in the over-trained athletes. Instead, over-trained athletes 
showed negative correlations between oxygen radical absorbance capacity at rest and protein carbonyls 
after exhaustive exercise indicating that increased oxidative stress may play a role in the pathophysiology 
of overtraining syndrome. Although these observations are not yet conclusive they indicate that 
adaptation to exercise is limited and that its protective effect can be exceeded leading to oxidative 
stress that cannot be dealt with by the endogenous antioxidant system. Whether it is helpful to apply 
exogenous antioxidants under such conditions as suggested still has to be elucidated. 
5. Training-Induced Muscular Adaptation, PGC-1 and ROS 
In addition to the above-described effects of exercise on contents and activities of antioxidant 
enzymes, regularly performed exercise in the form of endurance training leads to well described 
adaptations of the cardiovascular and muscular system. Important responses at the intramyocellular 
level include increases in size and number of mitochondria as well as such in the activities of oxidative 
enzymes [107–109]. In support of the increased oxidation of fatty acids, the content of intramyocellular 
lipid is also elevated [110]. Endurance exercise is also known to improve insulin sensitivity and 
muscular glucose uptake [108,111]. Recent research has demonstrated that ROS also have a beneficial 
role in promoting these adaptive responses of muscle to training. 
5.1. Role of PGC-1 in Exercise 
In rodents and humans, it has been demonstrated that peroxisome proliferator-activated receptor 
gamma coactivator-1 alpha (PGC-1) is a key regulator of the exercise-induced changes of muscle 
fibers towards a slow phenotype, as well as in the protection from muscle atrophy [108,112,113]. 
Several studies have shown that PGC-1 is upregulated after high-intensity training [114–118]. 
Activation of PGC-1 is likely to occur by phosphorylation of the PGC-1 protein by p38 MAPK 
together with NF-B [119], both of which are known to be activated by ROS [91,92]. PGC-1 has 
been demonstrated to regulate lipid and carbohydrate metabolism, and to improve the oxidative 
capacity of the muscle fibers by increasing the amount and activity of mitochondria through upregulation 
of nuclear respiratory factors (NRF-1, 2) and mitochondrial transcription factor A (TFAM) [120,121]. 
Furthermore, PGC-1 regulates genes involved in the determination of muscle fiber type. 
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Overexpression of PGC-1 increases the proportion of oxidative type I fibers [122] while PGC-1 
knock-out (KO) mice exhibit a shift from oxidative type I and IIA toward glycolytic type IID/X and 
IIB fibers [123]. This regulatory diversity of PGC-1 is enabled by its broad binding capacity to 
transcription factors in various signaling pathways. PGC-1 has multiple binding sites for the interactions 
with diverse coactivators. A domain between amino acids 200 and 400 interacts with the nuclear 
receptors PPAR and NRF-1 [124], which are considered as master regulators of mitochondrial 
biogenesis [125]. PGC-1 binds to and activates the transcriptional function of NRF-1 on the promoter 
for TFAM, a direct regulator of mitochondrial DNA replication and transcription [120]. Another domain 
that predominantly binds to nuclear hormone receptors such as ERR-, PPARs, RXR, glucocorticoid 
receptor, HNF4, and probably others, is an LXXLL sequence in the N-terminal region of PGC-1 [124]. 
This sequence is necessary for the coactivation of the nuclear receptor liver x receptor  (LXR) [126]. 
The transcription complex of LXR and PGC-1 then activates fatty acid synthase (FAS), a multifunctional 
enzyme that catalyzes all reactions required for the de novo biosynthesis of lipid [127]. The binding  
site of the nuclear receptor estrogen-related receptor  (ERR-) is also in the LXXLL region of  
PGC-1 [124]. The transcription complex formed by ERR- and PGC-1 induces the expression of 
vascular endothelial growth factor (VEGF), a potent stimulator of angiogenesis [128,129]. Between 
amino acids 400 to 500 of the PGC-1 protein is the binding site for myocyte enhancer factor 2 
(MEF2). This transcription factor is a key regulator of slow muscle identity [130]. MEF2 proteins are 
activated through the calcium-regulated calcineurin signaling pathway [130,131]. When overexpressed, 
MEF2C promotes the formation of slow fibers, thus enhancing running endurance in mice [132]. 
Genetic deletion of Mef2c has been shown to block activity-dependent (exercise-induced) fast-to-slow 
fiber type transition [132]. This is in line with the proposed role of PGC-1 in such transitions. 
Muscle-specific overexpression of PGC-1 has been shown to evoke a transition of glycolytic type II 
in oxidative type I fibers [122]. This shift is initiated by the formation of a PGC-1/MEF2 transcription 
complex, which then activates the expression of slow muscle genes [133]. Handschin et al. [123] have 
shown that PGC-1 deficient mice display a significant shift from slow oxidative type I and fast 
oxidative IIA toward fast glycolytic type IIX and IIB fibers, resulting in a reduced endurance capacity. 
5.2. PGC-1 Regulates ROS Defense 
It has been shown that oxidative stress increases the expression of PGC-1 [134]. Similarly, 
depleting the endogenous antioxidant glutathione augments exercise-mediated induction of PGC-1 
expression [135]. Upregulation of PGC-1 possibly involves the transcription factor Cre-binding protein 
(CREB) [136]. PGC-1 then induces an increase of ROS-detoxifying enzymes, including GPX1 and 
Mn-SOD [136]. Only recently, new light has been shed on the molecular mechanisms involved in 
antioxidant activation. Therefore, it is highly likely that PGC-1 binds to ERR- and activates the 
NAD+-dependent histone deacetylase silent information regulator 3 (SIRT3) in the mitochondrial 
matrix [137]. SIRT3 is also known to regulate ROS production by directly binding and deacetylating 
mitochondrial complex I and II [138,139]. Previous studies have also shown that SIRT3 is able to 
deacetylate the mitochondrial enzyme Mn-SOD, thereby promoting its antioxidative activity [140–142]. 
Thus, it appears that PGC-1 is a powerful suppressor of ROS production mainly by upregulation of 
antioxidant expression. Correspondingly, it was demonstrated that PGC-1 knock-out (KO) mice have 
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reduced expression levels of Mn-SOD, Cu, Zn-SOD and GPX1 and are thus more sensitive to oxidative 
stressors [136]. By contrast, overexpression of PGC-1 enhances antioxidant defense by upregulation 
of Mn-SOD expression and a higher catalase activity [143]. Further, PGC-1 increases the expression 
of uncoupling proteins 2 and 3 (UCP2, UCP3) and thereby concomitantly reduces mitochondrial ROS 
production [144]. 
6. Conclusions 
There is rapidly growing evidence that ROS have both positive and negative effects in contracting 
skeletal muscle cells. The deleterious effects such as a reduction of force generation and increased 
muscle atrophy appear to occur particularly after non-regular strenuous exercise, while regular training 
has positive effects by influencing cellular processes that lead to increased expression of antioxidants. 
These molecules then provide a better protection from ROS during subsequent trainings. However,  
a diet supplemented with exogenous antioxidants such as vitamins appears to prevent health-promoting 
effects of physical exercise in humans. The exercise-induced production of ROS may also be an 
important signal to activate PGC-1, a key player in the adaption of muscle cells to exercise. 
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